标题
Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy
作者
关键词
-
出版物
Pathogens
Volume 11, Issue 10, Pages 1146
出版商
MDPI AG
发表日期
2022-10-10
DOI
10.3390/pathogens11101146
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Infection of non-cancer cells: a barrier or support for oncolytic virotherapy?
- (2022) Victor A. Naumenko et al. Molecular Therapy-Oncolytics
- A phase I/II study of LOAd703, a TMZ-CD40L/4-1BBL-armed oncolytic adenovirus, combined with nab-paclitaxel and gemcitabine in advanced pancreatic cancer.
- (2022) Benjamin Leon Musher et al. JOURNAL OF CLINICAL ONCOLOGY
- Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma
- (2022) Alexander N. Shoushtari et al. CLINICAL CANCER RESEARCH
- Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple−Negative Breast Cancer Cell Lines
- (2022) Fu Hou Wong et al. Pharmaceuticals
- The structure of enteric human adenovirus 41—A leading cause of diarrhea in children
- (2021) K. Rafie et al. Science Advances
- Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy
- (2021) Jessica Wenthe et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform
- (2021) Erkko Ylösmäki et al. Molecular Therapy-Oncolytics
- Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1
- (2021) Riikka Havunen et al. Cells
- 1010P Intratumorally administered CV8102 in patients with advanced solid tumors: Preliminary results from completed dose escalation in study 008
- (2021) T. Eigentler et al. ANNALS OF ONCOLOGY
- Emerging strategies for sensitization of therapy resistant tumors toward cancer therapeutics by targeting the Bcl-2 family, TGF-β, Wnt/β-Catenin, RASSF and miRNA regulated signaling pathways
- (2021) Tarmarajen Veerasamy et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Stereotactic body radiation therapy and in situ oncolytic virus therapy followed by immunotherapy in metastatic non-small cell lung cancer.
- (2021) Carlo Guerrero et al. JOURNAL OF CLINICAL ONCOLOGY
- Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial
- (2021) Jawad Fares et al. LANCET ONCOLOGY
- Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
- (2021) Yaqi Zhao et al. Frontiers in Microbiology
- Concepts in Oncolytic Adenovirus Therapy
- (2021) Klaus Mantwill et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- 954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus
- (2021) Tereza Brachtlova et al. Journal for ImmunoTherapy of Cancer
- A phase I/II study combining a TMZ-CD40L/4-1BBL-armed oncolytic adenovirus and nab-paclitaxel/gemcitabine chemotherapy in advanced pancreatic cancer: An interim report.
- (2020) Benjamin Leon Musher et al. JOURNAL OF CLINICAL ONCOLOGY
- High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy
- (2020) Ana Ricobaraza et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tricistronic expression of MOAP-1, Bax and RASSF1A in cancer cells enhances chemo-sensitization that requires BH3L domain of MOAP-1
- (2020) Yong Hoi Lee et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Phase I/II study to evaluate systemic durvalumab + intraperitoneal (IP) ONCOS-102 in patients with peritoneal disease who have epithelial ovarian (OC) or metastatic colorectal cancer (CRC): Interim phase I clinical and translational results.
- (2020) Dmitriy Zamarin et al. JOURNAL OF CLINICAL ONCOLOGY
- Adenovirus and Immunotherapy: Advancing Cancer Treatment by Combination
- (2020) Mizuho Sato-Dahlman et al. Cancers
- Promising Gene Therapy Using an Adenovirus Vector Carrying REIC/Dkk-3 Gene for the Treatment of Biliary Cancer
- (2020) Emi Tanaka et al. CURRENT GENE THERAPY
- Localized Interleukin-12 for Cancer Immunotherapy
- (2020) Khue G. Nguyen et al. Frontiers in Immunology
- Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis
- (2019) Divya Thomas et al. Molecular Cancer
- Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
- (2019) Gaurav Nayyar et al. Frontiers in Oncology
- Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs
- (2019) Susannah L. Hewitt et al. Science Translational Medicine
- A review of 65 years of human adenovirus seroprevalence
- (2019) Franck J. D. Mennechet et al. Expert Review of Vaccines
- Tumor microenvironment as the “regulator” and “target” for gene therapy
- (2019) Jiayan Wu et al. JOURNAL OF GENE MEDICINE
- Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas
- (2019) Hong Jiang et al. CLINICAL CANCER RESEARCH
- Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8+ T Cells in HCC
- (2019) Yonghui Zhang et al. MOLECULAR THERAPY
- Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
- (2019) E. Antonio Chiocca et al. Science Translational Medicine
- No more helper adenovirus: production of gutless adenovirus (GLAd) free of adenovirus and replication-competent adenovirus (RCA) contaminants
- (2019) Dongwoo Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Immunology of Adenoviral Vectors in Cancer Therapy
- (2019) Amanda Rosewell Shaw et al. Molecular Therapy-Methods & Clinical Development
- Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma
- (2018) John A. Barrett et al. CANCER GENE THERAPY
- Armed oncolytic viruses: A kick-start for anti-tumor immunity
- (2018) J.F. de Graaf et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new therapeutic strategy for tumour immunotherapy
- (2018) Kui Li et al. JOURNAL OF DRUG TARGETING
- Adenovirus Coding for Interleukin-2 and Tumor Necrosis Factor Alpha Replaces Lymphodepleting Chemotherapy in Adoptive T Cell Therapy
- (2018) João Manuel Santos et al. MOLECULAR THERAPY
- Selective targeting of collagen IV in the cancer cell microenvironment reduces tumor burden
- (2018) Fernando Revert et al. Oncotarget
- Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies
- (2018) Shashi Gujar et al. OncoImmunology
- TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade
- (2018) V. Cervera-Carrascon et al. OncoImmunology
- Inhibition of Microsomal Prostaglandin E Synthase-1 in Cancer-Associated Fibroblasts Suppresses Neuroblastoma Tumor Growth
- (2018) Anna Kock et al. EBioMedicine
- Please stand by: how oncolytic viruses impact bystander cells
- (2018) Leslee Sprague et al. Future Virology
- CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapy
- (2018) Sadia Zafar et al. OncoImmunology
- Solid Tumor Immunotherapy with T Cell Engager-Armed Oncolytic Viruses
- (2017) Eleanor M. Scott et al. MACROMOLECULAR BIOSCIENCE
- Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer
- (2017) Amanda Rosewell Shaw et al. MOLECULAR THERAPY
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors
- (2017) J S K Chan et al. ONCOGENE
- Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
- (2017) Pengju Wang et al. Nature Communications
- A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model
- (2017) Julius W. Kim et al. Molecular Therapy-Oncolytics
- Oncolytic Viruses in Cancer Treatment
- (2017) Sean E. Lawler et al. JAMA Oncology
- Immune Checkpoint Inhibitors: Basics and Challenges
- (2017) Bin Li et al. CURRENT MEDICINAL CHEMISTRY
- Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer
- (2016) H Sawahara et al. CANCER GENE THERAPY
- Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention
- (2016) Adriana Kajon et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Adenovirus sensing by the immune system
- (2016) Svetlana Atasheva et al. Current Opinion in Virology
- E2F/Rb Family Proteins Mediate Interferon Induced Repression of Adenovirus Immediate Early Transcription to Promote Persistent Viral Infection
- (2016) Yueting Zheng et al. PLoS Pathogens
- Components of Adenovirus Genome Packaging
- (2016) Yadvinder S. Ahi et al. Frontiers in Microbiology
- Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers
- (2016) Tuuli Ranki et al. Journal for ImmunoTherapy of Cancer
- Biochanin A inhibits endothelial cell functions and proangiogenic pathways
- (2015) Aditi Jain et al. ANTI-CANCER DRUGS
- Adeno-associated virus-mediated cancer gene therapy: Current status
- (2015) Jingfeng Luo et al. CANCER LETTERS
- SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate
- (2015) Naoko Irie et al. CELL
- OX40, OX40L and Autoimmunity: a Comprehensive Review
- (2015) Gwilym J. Webb et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6Clow F4/80+ Extratumoral Macrophages
- (2015) Gregory L. Beatty et al. GASTROENTEROLOGY
- Immunological Effects of a Tumor Necrosis Factor Alpha–Armed Oncolytic Adenovirus
- (2015) Mari Hirvinen et al. HUMAN GENE THERAPY
- Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Resultsin vitro, in rodents and in humans
- (2015) Simona Bramante et al. INTERNATIONAL JOURNAL OF CANCER
- Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer
- (2015) Hee Jin Lee et al. JOURNAL OF CLINICAL PATHOLOGY
- Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy
- (2015) Palash Bhattacharya et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Pivotal Roles of GM-CSF in Autoimmunity and Inflammation
- (2015) Aoi Shiomi et al. MEDIATORS OF INFLAMMATION
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Tumor-specific oncolytic adenoviruses expressing granulocyte macrophage colony-stimulating factor or anti-CTLA4 antibody for the treatment of cancers
- (2014) T Du et al. CANCER GENE THERAPY
- Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
- (2014) William Wold et al. CURRENT GENE THERAPY
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Therapeutic vaccines for cancer: an overview of clinical trials
- (2014) Ignacio Melero et al. Nature Reviews Clinical Oncology
- Multifunctional CD40L: pro- and anti-neoplastic activity
- (2014) Aleksandra Korniluk et al. TUMOR BIOLOGY
- Safety and biodistribution of a double-deleted oncolytic vaccinia virus encoding CD40 ligand in laboratory Beagles
- (2014) Karoliina Autio et al. Molecular Therapy-Oncolytics
- Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
- (2013) Michael A. Morse et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus
- (2013) A. Kanerva et al. CLINICAL CANCER RESEARCH
- Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer
- (2013) Daisuke Uchida et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Differential Type I Interferon-dependent Transgene Silencing of Helper-dependent Adenoviral vs. Adeno-associated Viral Vectors In Vivo
- (2013) Masataka Suzuki et al. MOLECULAR THERAPY
- Cancer-associated fibroblasts as targets for immunotherapy
- (2012) Sunitha Kakarla et al. Immunotherapy
- Targeting Costimulatory Molecules to Improve Antitumor Immunity
- (2012) Daria Capece et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer
- (2012) James M. Burke et al. JOURNAL OF UROLOGY
- Anti-Angiogenic Activity of a Small Molecule STAT3 Inhibitor LLL12
- (2012) Hemant K. Bid et al. PLoS One
- Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of TH-302, a Hypoxia-Activated Prodrug, in Patients with Advanced Solid Malignancies
- (2011) G. J. Weiss et al. CLINICAL CANCER RESEARCH
- Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4
- (2011) J D Dias et al. GENE THERAPY
- Helper-dependent adenoviral vectors for liver-directed gene therapy
- (2011) N. Brunetti-Pierri et al. HUMAN MOLECULAR GENETICS
- Adenovirus
- (2011) Joseph Lynch et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Efficient co-expression of bicistronic proteins in mesenchymal stem cells by development and optimization of a multifunctional plasmid
- (2011) Christopher D Krause et al. Stem Cell Research & Therapy
- Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in vitro and in vivo
- (2010) S. S. Seregin et al. BLOOD
- Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA
- (2010) Elizabeth S. Gabitzsch et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Production of adenovirus vectors and their use as a delivery system for influenza vaccines
- (2010) Sai V Vemula et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Metronomic Small Molecule Inhibitor of Bcl-2 (TW-37) Is Antiangiogenic and Potentiates the Antitumor Effect of Ionizing Radiation
- (2010) Benjamin D. Zeitlin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The Junctional Adhesion Molecule JAML Is a Costimulatory Receptor for Epithelial T Cell Activation
- (2010) D. A. Witherden et al. SCIENCE
- Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles
- (2010) Han Hsi Wong et al. Viruses-Basel
- GM-CSF: a role in immune and inflammatory reactions in the intestine
- (2010) Laia Egea et al. Expert Review of Gastroenterology & Hepatology
- The Role of Adenovirus in Respiratory Tract Infections
- (2010) Anjali N. Kunz et al. Current Infectious Disease Reports
- Bicarbonate Increases Tumor pH and Inhibits Spontaneous Metastases
- (2009) I. F. Robey et al. CANCER RESEARCH
- Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL
- (2009) Jing-Hua Huang et al. MOLECULAR THERAPY
- Ex vivo detection of adenovirus specific CD4+ T-cell responses to HLA-DR-epitopes of the Hexon protein show a contracted specificity of THELPER cells following stem cell transplantation
- (2009) Celine Serangeli et al. VIROLOGY
- REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer
- (2008) K Kawasaki et al. CANCER GENE THERAPY
- A Phase 1 Open-Label, Accelerated Dose-Escalation Study of the Hypoxia-Activated Prodrug AQ4N in Patients with Advanced Malignancies
- (2008) K. P. Papadopoulos et al. CLINICAL CANCER RESEARCH
- Carbamoylphosphonate Matrix Metalloproteinase Inhibitors 6:cis-2-Aminocyclohexylcarbamoylphosphonic Acid, A Novel Orally Active Antimetastatic Matrix Metalloproteinase-2 Selective InhibitorSynthesis and Pharmacodynamic and Pharmacokinetic Analysis
- (2008) Amnon Hoffman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role for the L1-52/55K Protein in the Serotype Specificity of Adenovirus DNA Packaging
- (2008) B. P. Wohl et al. JOURNAL OF VIROLOGY
- The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response
- (2008) Daniel A. Muruve et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started